C. diff especially deadly for those with kidney disease, researchers find

Share this article:

People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.

Researchers at Albert Einstein School of Medicine's Jacobi Medical Center in New York City compared outcomes of 104 ESRD patients on dialysis with a 300-person control group. They found those in the ESRD group had a C. diff-related mortality rate of 3.8%, while the other group's rate was 1.46%. ESRD patients were also more likely to have a relapse of severe C. diff infection within two months.

Combinining metronidazole and oral or rectal vancomycin was more effective than monotherapy drug treatment for the ESRD patients with C. diff, the researchers said. The monotherapy was associated with increased chances of a relapse, they found.

The research was released at the National Kidney Foundation 2013 Spring Clinical Meetings, held last week in Orlando, FL.

Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.